{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:59:49Z","timestamp":1761469189883,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.transci.2022.103520","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T23:35:28Z","timestamp":1661297728000},"page":"103520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Investigation of the potential of leukoreduction filters in the creation of anti-inflammatory compound"],"prefix":"10.1016","volume":"62","author":[{"given":"Sahar","family":"Balagholi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasul","family":"Dabbaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Abbasi Malati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Javan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pyman","family":"Eshghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.transci.2022.103520_bib1","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","article-title":"Anti-inflammatory cytokines","volume":"117","author":"Opal","year":"2000","journal-title":"Chest"},{"issue":"6917","key":"10.1016\/j.transci.2022.103520_bib2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.transci.2022.103520_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ccm.2008.06.010","article-title":"The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients","volume":"29","author":"Ward","year":"2008","journal-title":"Clin Chest Med"},{"issue":"6917","key":"10.1016\/j.transci.2022.103520_bib4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nature01321","article-title":"The inflammatory reflex","volume":"420","author":"Tracey","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.transci.2022.103520_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155143","article-title":"Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions","volume":"133","author":"Noroozi","year":"2020","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.transci.2022.103520_bib6","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives the development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.transci.2022.103520_bib7","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2337\/dbi19-0023","article-title":"Aging, male sex, obesity, and metabolic inflammation create the perfect storm for COVID-19","volume":"69","author":"Mauvais-Jarvis","year":"2020","journal-title":"Diabetes"},{"issue":"14","key":"10.1016\/j.transci.2022.103520_bib8","doi-asserted-by":"crossref","first-page":"7062","DOI":"10.1128\/JVI.00127-09","article-title":"Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection","volume":"83","author":"Rockx","year":"2009","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.transci.2022.103520_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5619","article-title":"Clinical characteristics of patients who died of coronavirus disease 2019 in China","volume":"3","author":"Xie","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.transci.2022.103520_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saltiel","year":"2017","journal-title":"J Clin Investig"},{"issue":"2","key":"10.1016\/j.transci.2022.103520_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.transci.2022.103520_bib12","article-title":"Effective treatment of severe COVID-19 patients with Tocilizumab","author":"Xu","year":"2020","journal-title":"ChinaXiv"},{"key":"10.1016\/j.transci.2022.103520_bib13","unstructured":"Pan Luo, Yi Liu, Lin Qiu, Xiulan Liu, Dong Liu*, Juan Li* Tocilizumab treatment in COVID-19: a single center experience, This article is protected by copyright. All rights reserved. \u3008https:\/\/onlinelibrary.wiley.com\/doi\/epdf\/10.1002\/jmv.25801\u3009."},{"issue":"1","key":"10.1016\/j.transci.2022.103520_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03137-5","article-title":"Effect of favipiravir and an anti-inflammatory strategy for COVID-19","volume":"24","author":"Yamamura","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2022.103520_bib15","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","article-title":"Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment","volume":"39","author":"Soy","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.transci.2022.103520_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"issue":"10","key":"10.1016\/j.transci.2022.103520_bib17","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00011-003-1197-1","article-title":"The production of anti-inflammatory cytokines in whole blood by Physico-chemical induction","volume":"52","author":"Meijer","year":"2003","journal-title":"Inflamm Res"},{"issue":"3","key":"10.1016\/j.transci.2022.103520_bib18","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar3050","article-title":"Cytokine profile of autologous conditioned serum for the treatment of osteoarthritis, in vitroeffects on cartilage metabolism and intra-articular levels after injection","volume":"12","author":"Rutgers","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.transci.2022.103520_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1759720X17712695","article-title":"Effectiveness of intra-articular therapies in osteoarthritis: a literature review","volume":"9","author":"Wehling","year":"2017","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"10.1016\/j.transci.2022.103520_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0887-7963(05)80053-7","article-title":"The mechanisms of leukocyte removal by filtration","volume":"9","author":"Bruil","year":"1995","journal-title":"Transfus Med Rev"},{"issue":"5","key":"10.1016\/j.transci.2022.103520_bib21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/jp.2014.16","article-title":"Anti-inflammatory actions of endogenous and exogenous interleukin-10 versus glucocorticoids on macrophage functions of the newly born","volume":"34","author":"Kasat","year":"2014","journal-title":"J Perinatol"},{"issue":"3","key":"10.1016\/j.transci.2022.103520_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/CVI.00636-12","article-title":"Targeting the \u201ccytokine storm\u201d for therapeutic benefit","volume":"20","author":"D'Elia","year":"2013","journal-title":"Clin Vaccin Immunol"},{"issue":"1","key":"10.1016\/j.transci.2022.103520_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cmi.2015.74","article-title":"The cytokine storm of severe influenza and the development of immunomodulatory therapy","volume":"13","author":"Liu","year":"2016","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"10.1016\/j.transci.2022.103520_bib24","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1517\/13543784.9.7.1651","article-title":"Anti-inflammatory therapies in sepsis and septic shock","volume":"9","author":"Freeman","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10.1016\/j.transci.2022.103520_bib25","first-page":"535","article-title":"Anti-inflammatory and immune support in endotoxemia and septicemia","volume":"10","author":"Holbrook","year":"1994","journal-title":"Vet Clin North Am: Equine Pract"},{"issue":"6","key":"10.1016\/j.transci.2022.103520_bib26","doi-asserted-by":"crossref","first-page":"R1885","DOI":"10.1152\/ajpregu.1997.273.6.R1885","article-title":"Epinephrine inhibits endotoxin-induced IL-1\u03b2 production: roles of tumor necrosis factor-\u03b1 and IL-10","volume":"273","author":"Van Der Poll","year":"1997","journal-title":"Am J Physiol-Regul Integr Comp Physiol"},{"issue":"5","key":"10.1016\/j.transci.2022.103520_bib27","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/iai.62.5.2046-2050.1994","article-title":"Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood","volume":"62","author":"Van der Poll","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.transci.2022.103520_bib28","first-page":"10","article-title":"Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs","author":"Weiss","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.transci.2022.103520_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100019","article-title":"Mesenchymal stem cells and management of COVID-19 pneumonia","author":"Metcalfe","year":"2020","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.transci.2022.103520_bib30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.actbio.2017.01.071","article-title":"Generation of anti-inflammatory macrophages for implants and regenerative medicine using self-standing release systems with a phenotype-fixing cytokine cocktail formulation","volume":"53","author":"Riabov","year":"2017","journal-title":"Acta Biomater"},{"issue":"8","key":"10.1016\/j.transci.2022.103520_bib31","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4103\/1673-5374.253510","article-title":"Role of macrophages in peripheral nerve injury and repair","volume":"14","author":"Liu","year":"2019","journal-title":"Neural Regen Res"},{"issue":"2","key":"10.1016\/j.transci.2022.103520_bib32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1084\/jem.176.2.593","article-title":"Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte\/macrophage colony-stimulating factor and tumor necrosis factor alpha","volume":"176","author":"16-McColl","year":"1992","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.transci.2022.103520_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF01541172","article-title":"Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1\u03b2","volume":"14","author":"Malyak","year":"1994","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.transci.2022.103520_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cyto.2016.03.008","article-title":"A method to induce Interleukin-1 Receptor Antagonist Protein from autologous whole blood","volume":"81","author":"Barreto","year":"2016","journal-title":"Cytokine"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022200204X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022200204X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:55:09Z","timestamp":1761468909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147305022200204X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S147305022200204X"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2022.103520","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the potential of leukoreduction filters in the creation of anti-inflammatory compound","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2022.103520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103520"}}